Transcriptomics

Dataset Information

0

BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion


ABSTRACT: B- and T-lymphocyte attenuator (BTLA) levels are increased in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). This condition is characterized by susceptibility to infection and T-cell immune exhaustion. However, whether BTLA can induce T-cell immune exhaustion and increase the risk of infection remains unclear. Here, we report that BTLA levels are significantly increased in the circulating and intrahepatic CD4+ T cells from patients with HBV-ACLF, and are positively correlated with disease severity, prognosis, and infection complications. BTLA levels are upregulated by the IL-6 and TNF signaling pathways, and are abolished or partially weakened by IL-6 and TNF inhibitors. Antibody crosslinking of BTLA activated the PI3K-Akt pathway to inhibit the activation, proliferation, and cytokine production of CD4+ T cells while promoting their apoptosis. In contrast, BTLA knockdown promoted their activation and proliferation. BTLA-/- ACLF mice exhibited increased cytokine secretion, and reduced mortality and bacterial burden. The administration of a neutralizing anti-BTLA antibody reduced Klebsiella pneumoniae load and mortality in ACLF mice. These data help elucidate HBV-ACLF pathogenesis and aid in identifying novel drug targets.

ORGANISM(S): Homo sapiens

PROVIDER: GSE248217 | GEO | 2023/12/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-01-03 | E-GEOD-43260 | biostudies-arrayexpress
2024-05-27 | GSE239586 | GEO
2022-12-12 | GSE207471 | GEO
2013-01-03 | GSE43260 | GEO
| PRJNA1042852 | ENA
2024-11-06 | GSE269212 | GEO
2018-10-23 | PXD007975 | Pride
| PRJNA926654 | ENA
2019-05-06 | PXD010863 | Pride
2023-07-22 | GSE223534 | GEO